Expression of the Multiple Sclerosis-Associated MHC Class II Allele Is Regulated by Vitamin D

English version České info

Multiple sclerosis (MS) is a complex trait in which allelic variation in the MHC class II region exerts the single strongest effect on genetic risk. Epidemiological data in MS provide strong evidence that environmental factors act at a population level to influence the unusual geographical distribution of this disease. Growing evidence implicates sunlight or vitamin D as a key environmental factor in aetiology. We hypothesised that this environmental candidate might interact with inherited factors and sought responsive regulatory elements in the MHC class II region. Sequence analysis localised a single MHC vitamin D response element (VDRE) to the promoter region of HLA-DRB1. Sequencing of this promoter in greater than 1,000 chromosomes from HLA-DRB1 homozygotes showed absolute conservation of this putative VDRE on HLA-DRB1*15 haplotypes. In contrast, there was striking variation among non–MS-associated haplotypes. Electrophoretic mobility shift assays showed specific recruitment of vitamin D receptor to the VDRE in the HLA-DRB1*15 promoter, confirmed by chromatin immunoprecipitation experiments using lymphoblastoid cells homozygous for HLA-DRB1*15. Transient transfection using a luciferase reporter assay showed a functional role for this VDRE. B cells transiently transfected with the HLA-DRB1*15 gene promoter showed increased expression on stimulation with 1,25-dihydroxyvitamin D3 (P = 0.002) that was lost both on deletion of the VDRE or with the homologous “VDRE” sequence found in non–MS-associated HLA-DRB1 haplotypes. Flow cytometric analysis showed a specific increase in the cell surface expression of HLA-DRB1 upon addition of vitamin D only in HLA-DRB1*15 bearing lymphoblastoid cells. This study further implicates vitamin D as a strong environmental candidate in MS by demonstrating direct functional interaction with the major locus determining genetic susceptibility. These findings support a connection between the main epidemiological and genetic features of this disease with major practical implications for studies of disease mechanism and prevention.

Vyšlo v časopise: Expression of the Multiple Sclerosis-Associated MHC Class II Allele Is Regulated by Vitamin D. PLoS Genet 5(2): e32767. doi:10.1371/journal.pgen.1000369
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1000369

Souhrn

Zdroje

1. NoseworthyJH

LucchinettiC

RodriguezM

WeinshenkerBG

2000 Multiple sclerosis. N Engl J Med 343 938 952

2. EbersGC

2008 Environmental factors and multiple sclerosis. Lancet Neurol 7 268 277

3. RamagopalanSV

EbersGC

2008 Genes for multiple sclerosis. Lancet 371 283 285

4. LundmarkF

DuvefeltK

IacobaeusE

KockumI

WallstromE

2007 Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet

5. HaflerDA

CompstonA

SawcerS

LanderES

DalyMJ

2007 Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357 851 862

6. HoppenbrouwersIA

AulchenkoYS

EbersGC

RamagopalanSV

OostraBA

2008 EVI5 is a risk gene for multiple sclerosis. Genes Immun

7. AulchenkoYS

HoppenbrouwersIA

RamagopalanSV

BroerL

JafariN

2008 Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet

8. FogdellA

HillertJ

SachsC

OlerupO

1995 The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens 46 333 336

9. DymentDA

HerreraBM

CaderMZ

WillerCJ

LincolnMR

2005 Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 14 2019 2026

10. RamagopalanSV

MorrisAP

DymentDA

HerreraBM

DelucaGC

2007 The Inheritance of Resistance Alleles in Multiple Sclerosis. PLoS Genet 3 e150

11. ModinH

OlssonW

HillertJ

MastermanT

2004 Modes of action of HLA-DR susceptibility specificities in multiple sclerosis. Am J Hum Genet 74 1321 1322

12. MarrosuMG

MurruMR

CostaG

CuccaF

SotgiuS

1997 Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am J Hum Genet 61 454 457

13. DeLucaGC

RamagopalanSV

HerreraBM

DymentDA

LincolnMR

2007 An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Natl Acad Sci U S A 104 20896 20901

14. WillerCJ

DymentDA

RischNJ

SadovnickAD

EbersGC

2003 Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 100 12877 12882

15. HammondSR

McLeodJG

MillingenKS

Stewart-WynneEG

EnglishD

1988 The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 111(Pt 1) 1 25

16. PugliattiM

SotgiuS

RosatiG

2002 The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 104 182 191

17. AchesonED

BachrachCA

WrightFM

1960 Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr Scand Suppl 35132 147

18. NievesJ

CosmanF

HerbertJ

ShenV

LindsayR

1994 High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44 1687 1692

19. MungerKL

LevinLI

HollisBW

HowardNS

AscherioA

2006 Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Jama 296 2832 2838

20. WillerCJ

DymentDA

SadovnickAD

RothwellPM

MurrayTJ

2005 Timing of birth and risk of multiple sclerosis: population based study. Bmj 330 120

21. SmoldersJ

DamoiseauxJ

MenheereP

HuppertsR

2008 Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol

22. FeldmanD

GlorieuxFH

PikeJW

2005 Vitamin D San Diego; London Academic Press

23. HolickMF

2003 Vitamin D: A millenium perspective. J Cell Biochem 88 296 307

24. RigbyWF

WaughM

GrazianoRF

1990 Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood 76 189 197

25. SkjodtH

HughesDE

DobsonPR

RussellRG

1990 Constitutive and inducible expression of HLA class II determinants by human osteoblast-like cells in vitro. J Clin Invest 85 1421 1426

26. SandelinA

AlkemaW

EngstromP

WassermanWW

LenhardB

2004 JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32 D91 94

27. DeanG

ElianM

1997 Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 63 565 568

28. EbersGC

SadovnickAD

RischNJ

1995 A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377 150 151

29. ReithW

LeibundGut-LandmannS

WaldburgerJM

2005 Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 5 793 806

30. AnderssonG

1998 Evolution of the human HLA-DR region. Front Biosci 3 d739 745

31. AhmadT

NevilleM

MarshallSE

ArmuzziA

Mulcahy-HawesK

2003 Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet 12 647 656

32. WalkerLS

AbbasAK

2002 The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2 11 19

33. YuS

CantornaMT

2008 The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A 105 5207 5212

34. JablonskiNG

ChaplinG

2000 The evolution of human skin coloration. J Hum Evol 39 57 106

35. LookerAC

Dawson-HughesB

CalvoMS

GunterEW

SahyounNR

2002 Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30 771 777

36. SadovnickAD

RischNJ

EbersGC

1998 Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 25 216 221

37. KrugerA

QuackP

SchneiderPM

RittnerC

HohlerT

2001 Sequence analysis of the DRB1 promoter reveals limited polymorphism with no influence on gene expression. Genes Immun 2 211 215

38. KnightJC

KeatingBJ

KwiatkowskiDP

2004 Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. Nat Genet 36 394 399

39. KnightJC

KeatingBJ

RockettKA

KwiatkowskiDP

2003 In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 33 469 475

40. SaramakiA

BanwellCM

CampbellMJ

CarlbergC

2006 Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 34 543 554